How do you decide between neoadjuvant or perioperative chemoimmunotherapy, as per Checkmate 816 or KEYNOTE-671, for early-stage NSCLC?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Onc San Antonio
Amazing review! 
Medical Oncologist at Virginia Oncology Associates
Great review of this difficult question. One quest...
Medical Oncologist at Albert Einstein College of Medicine at Montefiore Medical Center
Great question - I might just say we have to use c...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice